David McGiffin, MD

Original Contribution

How Much Alcohol Should We Infuse in the Coronary Artery of Hypertrophic Cardiomyopathy Patients?

01/07/2010

Koteswara Pothineni , MD;

Wael AlJaroudi , MD, MS;

Jaekyeong Heo , MD;

Octavio Pajaro , MD;

David McGiffin , MD;

Ami E. Iskandrian , MD;

Raed A. Aqel , MD;

Fadi G. Hage , MD;

Louis Dell'italia , MD;

David Lawson , PA;

Aaron Sweeney , MD;

Sachin Hansalia , MD;

ABSTRACT: Background. Although alcohol septal ablation (ASA) is increasingly used in hypertrophic cardiomyopathy (HC) patients who are refractory to medical therapy, the amount of alcohol that is required has not been well studied. This study...

ABSTRACT: Background. Although...

01/07/2010

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

David McGiffin, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products